Ayala Pharmaceuticals Inc (ADXS)

[mpreorder]

The only trials with HER2 with results are the canine osteosarcoma trials, which were successful and should lead to approval later this year.

There was a trial planned that is listed as "not recruiting" for HER2 expressing solid tumors on clinicaltrials.gov. So to my knowledge there haven't been any trials in humans using HER2.
Lombardo seems to be selling or licensing this construct to raise capital for other uses.